Results 11 to 20 of about 176,389 (357)
NAFLD: a multisystem disease. [PDF]
Journal of Hepatology, 2015 Non-alcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease in Western countries that is predicted to become also the most frequent indication for liver transplantation by 2030. Over the last decade, it has been shown that
C. Byrne, G. Targher
semanticscholar +6 more sources
Immunotherapy for NAFLD and NAFLD-related hepatocellular carcinoma [PDF]
Frontiers in Endocrinology, 2023 The progression of non-alcoholic fatty liver disease (NAFLD), the most common liver disease, leads to non-alcoholic steatohepatitis and hepatocellular carcinoma. Despite the increasing incidence and prevalence of NAFLD, its therapeutic and preventive strategies to lower the disease burden is limited.
Seogsong Jeong +3 more
openaire +4 more sources
The role of hepatokines in NAFLD
Cell Metabolism, 2023 SUMMARY Non-alcoholic fatty liver disease (NAFLD) is not only a consequence of insulin resistance, but it is also an important cause of insulin resistance and major non-communicable diseases (NCDs).
Norbert Stefan +4 more
semanticscholar +4 more sources
JHEP Reports, 2021 Non-alcoholic fatty liver disease (NAFLD) is a growing cause of chronic liver disease worldwide. It is characterised by steatosis, liver inflammation, hepatocellular injury and progressive fibrosis. Several preclinical models (dietary and genetic animal models) of NAFLD have deepened our understanding of its aetiology and pathophysiology.
Parlati, Lucia +3 more
openaire +4 more sources
Advancing the global public health agenda for NAFLD: a consensus statement
Nature reviews: Gastroenterology & hepatology, 2021 Non-alcoholic fatty liver disease (NAFLD) is a potentially serious liver disease that affects approximately one-quarter of the global adult population, causing a substantial burden of ill health with wide-ranging social and economic implications. It is a
J. Lazarus +220 more
semanticscholar +2 more sources
Why are there no strategies for NAFLD? [PDF]
Journal of Hepatology, 2022 Byrne, Christopher +2 more
openaire +3 more sources
Clinical Interventions in Aging, 2021 Non-alcoholic fatty liver disease (NAFLD) is an increasingly prevalent disease globally. Current estimates are that 24% of the adult population, thus, one billion individuals worldwide, are affected. Interestingly, the prevalence of fatty liver seems to peak between 40─50 years of age in males and 60─69 years in females, often slightly decreasing in ...
Saleh A Alqahtani, Jörn M Schattenberg
openaire +3 more sources
Frontiers in Medicine, 2022 Background and Aim(s)Liver steatosis, as the main feature of metabolic associated fatty liver disease (MAFLD), was associated with the progression of liver fibrosis and metabolic syndrome, which needed to be estimated accurately.
Rui Jin +7 more
doaj +1 more source
Advancements in the treatment of non-alcoholic fatty liver disease (NAFLD)
Frontiers in Endocrinology, 2023 Non-alcoholic fatty liver disease (NAFLD) is a series of diseases, involving excessive lipid deposition in the liver and is often accompanied by obesity, diabetes, dyslipidemia, abnormal blood pressure, and other metabolic disorders.
L. Rong +6 more
semanticscholar +1 more source
NAFLD or comorbidities, that is the question [PDF]
Journal of Hepatology, 2020 N ...
Ponziani F. R. +2 more
openaire +3 more sources